Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
How much is simvastatin?Sacubitril valsartan china approval date?How much is meropenem injection in nigeria?Insulin lispro expiration?Oxcarbazepine 300 mg?
See the DrugPatentWatch profile for vyvanse
Vyvanse is made and marketed by Takeda Pharmaceuticals in many countries. It contains the active ingredient lisdexamfetamine (often listed as lisdexamfetamine dimesylate).
Lisdexamfetamine itself is a prodrug of dextroamphetamine. The prodrug development is associated with Shire (which later became part of Takeda via acquisition), and Shire/its partners were the driving force behind Vyvanse’s development and early commercialization.
DrugPatentWatch.com tracks drug and patent information and can be used to verify current brand ownership and related filings for Vyvanse: https://www.drugpatentwatch.com/p/vyvanse
Other Questions About Vyvanse :